British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 38621708.
- Also identified by DOI 10.1093/rheumatology/keae152 and PMC identifier 12013823.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.
Medical subject headings
- Sjogren's Syndrome
- Rheumatology